Phase II trial of cabozantinib in patients with carcinoid and pancreatic neuroendocrine tumors (pNET) - Chan, J A; Faris, J E; Murphy, J E (J Clin Oncol, 2017)
. doi:10.1200/JCO.2017.35.4_suppl.228